I

Innocan Pharma Corp
OTC:INNPF

Watchlist Manager
Innocan Pharma Corp
OTC:INNPF
Watchlist
Price: 5.46 USD
Market Cap: $1.5B

Income Statement

Earnings Waterfall
Innocan Pharma Corp

Income Statement
Innocan Pharma Corp

Rotate your device to view
Income Statement
Currency: USD
Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
+61%
0
+37%
0
+114%
1
+78%
1
+93%
3
+78%
4
+51%
7
+70%
10
+51%
14
+38%
19
+38%
24
+29%
29
+19%
29
+2%
30
+3%
29
-5%
27
-6%
Gross Profit
Cost of Revenue
0
0
(0)
0
0
0
(0)
(0)
(0)
(0)
(1)
(1)
(0)
(0)
(0)
(1)
(2)
(2)
(2)
(3)
(3)
(3)
(3)
(3)
Gross Profit
0
N/A
0
N/A
(0)
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
+55%
0
+39%
0
+50%
0
-8%
1
+247%
2
+263%
3
+64%
6
+76%
9
+53%
12
+29%
17
+39%
22
+32%
26
+19%
26
+0%
27
+4%
25
-7%
24
-6%
Operating Income
Operating Expenses
(2)
(3)
(3)
(4)
(5)
(4)
(2)
(3)
(8)
(7)
(8)
(8)
(8)
(9)
(10)
(14)
(16)
(20)
(25)
(27)
(27)
(27)
(25)
(25)
Selling, General & Administrative
(1)
(2)
(3)
(3)
(4)
(3)
(1)
(2)
(6)
(5)
(6)
(6)
(7)
(8)
(9)
(12)
(14)
(19)
(23)
(26)
(26)
(36)
(34)
(34)
Research & Development
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(1)
(1)
(1)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
10
Operating Income
(2)
N/A
(3)
-80%
(3)
-7%
(4)
-20%
(5)
-30%
(4)
+8%
(2)
+48%
(3)
-20%
(7)
-176%
(7)
+9%
(8)
-13%
(7)
+7%
(6)
+12%
(6)
+9%
(4)
+27%
(4)
-4%
(4)
+12%
(4)
+1%
(3)
+26%
(1)
+56%
(1)
-2%
0
N/A
0
-30%
(1)
N/A
Pre-Tax Income
Interest Income Expense
(0)
(2)
(0)
0
(0)
2
(0)
(2)
(3)
1
1
4
(0)
1
1
(0)
(0)
(0)
1
2
(0)
1
0
(0)
Total Other Income
0
0
0
0
0
0
0
0
0
(0)
0
0
3
0
0
0
0
0
0
0
2
0
(0)
(0)
Pre-Tax Income
(2)
N/A
(5)
-211%
(3)
+32%
(3)
-1%
(5)
-43%
(3)
+43%
(3)
+6%
(5)
-80%
(10)
-116%
(6)
+41%
(7)
-13%
(3)
+51%
(4)
-17%
(4)
-13%
(3)
+33%
(5)
-56%
(4)
+13%
(4)
+0%
(2)
+45%
0
N/A
1
+175%
2
+136%
1
-71%
(2)
N/A
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
Income from Continuing Operations
(2)
(5)
(3)
(3)
(5)
(3)
(3)
(5)
(10)
(6)
(7)
(3)
(4)
(4)
(3)
(5)
(4)
(4)
(3)
(1)
(0)
1
(0)
(2)
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
Net Income (Common)
(2)
N/A
(5)
-211%
(3)
+32%
(3)
-1%
(5)
-43%
(3)
+43%
(3)
+6%
(5)
-79%
(10)
-116%
(6)
+41%
(7)
-12%
(3)
+52%
(4)
-20%
(4)
-16%
(3)
+28%
(5)
-59%
(5)
+6%
(5)
-11%
(4)
+16%
(3)
+40%
(2)
+30%
(1)
+65%
(2)
-143%
(3)
-105%
EPS (Diluted)
-0.71
N/A
-2.85
-301%
-1.79
+37%
-1.52
+15%
-2.06
-36%
-1.01
+51%
-0.76
+25%
-1.32
-74%
-2.9
-120%
-1.53
+47%
-1.72
-12%
-0.81
+53%
-0.98
-21%
-1.13
-15%
-0.81
+28%
-1.26
-56%
-1.19
+6%
-1.25
-5%
-1
+20%
-0.6
+40%
-0.43
+28%
-0.16
+63%
-0.35
-119%
-0.72
-106%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett